HRGN Harvard Apparatus Regenerative Technology, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $400K and sold $0 on the open market; over its last four quarters it reported revenue of $982K and net income of −$6.68M.
HRGN revenue and earnings
- Quarter ended Jun 30, 2026: revenue $414K, net income −$1.70M
- Quarter ended Mar 31, 2026: revenue $226K, net income −$1.60M
- Quarter ended Dec 31, 2025: revenue $219K, net income −$1.69M
- Quarter ended Sep 30, 2025: revenue $123K, net income −$1.70M
Recent HRGN insider trades
- Sep 15, 2026: He Junli bought 368,630 shares ($394K)
- Nov 25, 2025: He Junli bought 3,000 shares ($5.10K)
- Sep 30, 2025: He Junli bought 300 shares ($594)
- Sep 2, 2025: He Junli bought 11,225 shares ($20.8K)
Are insiders buying or selling HRGN?
Over the last 12 months insiders bought $400K and sold $0 of Harvard Apparatus Regenerative Technology, Inc. stock on the open market (SEC Form 4).
What was HRGN's revenue last quarter?
Harvard Apparatus Regenerative Technology, Inc. reported revenue of $414K for the quarter ended June 30, 2026, with net income of −$1.70M.